Achilles Therapeutics PL-ADRACHL
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 27 institutions reported holding Achilles Therapeutics PL-ADR (ACHL) in their 13F filings, down 5 from Q1 2024. 3 opened new positions and 8 sold out. The largest holders were Syncona Portfolio Ltd ($9.0M), FCPM III Services B.V. ($1.9M) and Redmile Group, LLC ($1.3M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Achilles Therapeutics PL-ADR
- CUSIP
- 00449L102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $571K |
| Exits | 8 | $1.9M |
All 13F filers, Q1 2024 → Q2 2024: 757,795 shares bought and 2,079,601 shares sold, net −1,321,806 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Syncona Portfolio Ltd | 10.52% | No change | 11,086,909 | $9.0M |
| FCPM III Services B.V. | 0.29% | No change | 2,390,050 | $1.9M |
| Redmile Group, LLC | 0.08% | No change | 1,608,089 | $1.3M |
| Vestal Point Capital, LP | 0.09% | No change | 1,500,000 | $1.2M |
| Ikarian Capital, LLC | 0.37% | No change | 1,443,181 | $1.2M |
| Baker Bros. Advisors LP | 0.01% | Reduce -8.3% | 1,108,767 | $904K |
| Artal Group S.A. | 0.02% | No change | 755,375 | $616K |
| Renaissance Technologies | 0.00% | Reduce -32.1% | 682,734 | $556K |
| BML Capital Management, LLC | 0.37% | New | 625,174 | $510K |
| Boothbay Fund Management, LLC | 0.01% | No change | 420,481 | $343K |
| Acadian Asset Management LLC | 0.00% | Reduce -10.7% | 250,825 | $203K |
| UBS Group AG | 0.00% | New | 65,700 | $54K |
| Citadel Advisors | 0.00% | Reduce -41.5% | 61,391 | $50K |
| XTX Topco Ltd | 0.00% | Add +239.4% | 51,660 | $42K |
| Two Sigma Advisers, LP | 0.00% | Add +31.3% | 23,500 | $19K |
| Virtu Financial LLC | 0.00% | Add +8.9% | 22,813 | $19K |
| Geode Capital Management, LLC | 0.00% | No change | 21,590 | $18K |
| Two Sigma Investments, LP | 0.00% | Add +82.0% | 21,478 | $18K |
| Baader Bank Aktiengesellschaft | 0.00% | New | 12,369 | $8K |
| Brave Asset Management Inc. | 0.00% | No change | 10,000 | $8K |
| HRT Financial LP | 0.00% | Reduce -70.4% | 10,942 | $8K |
| Morgan Stanley | 0.00% | Reduce -50.9% | 8,931 | $7K |
| Rhumbline Advisers | 0.00% | Add +27.5% | 4,480 | $4K |
| Global Retirement Partners, LLC | 0.00% | No change | 2,000 | $2K |
| JPMorgan Chase & Co. | 0.00% | No change | 137 | $112 |
| Qube Research & Technologies Ltd | 0.00% | No change | 73 | $59 |
| Royal Bank of Canada | 0.00% | No change | 35 | $0 |
"% of holder's portfolio" is ACHL's weight in each manager's 13F, not the share of Achilles Therapeutics PL-ADR the manager owns.